Warwick Investment Management »

Lineage Cell Therapeutics In shares owned by Warwick Investment Management

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Warwick Investment Management from 13F filings

Historical chart of Warwick Investment Management investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Warwick Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Warwick Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $15k 11k 1.31

More positions owned by Warwick Investment Management

Schwab Strategic Tr 1000 Index Etf (SCHK)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Vanguard Index Fds Value Etf (VTV)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Scottsdale Fds Total Corp Bnd (VTC)
Vanguard Admiral Fds Smllcp 600 Idx (VIOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Select Sector Spdr Tr St Str Real Etf (XLRE)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Bd Index Fds Vanguard Ultra (VUSB)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Admiral Fds Midcp 400 Idx (IVOO)
Dimensional Etf Trust Us Equi Mark Etf (DFUS)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)

View all positions for Warwick Investment Management

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Capital Management
Defender Capital
Millennium Management
Raffles Associates
Fifth Third Bancorp
BlackRock
Armistice Capital
Marshall Wace
Geode Capital Management
Renaissance Technologies
Morgan Stanley
Susquehanna International
UBS Group
Vanguard Fiduciary Trust

View all funds holding Lineage Cell Therapeutics In